Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells

• Egile Nagusiak: Anna Egorova (Egilea), Alexander Selutin (Egilea), Marianna Maretina (Egilea), Sergei Selkov (Egilea), Vladislav Baranov (Egilea), Anton Kiselev (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Efficient and specific delivery of nucleic acid (NA) therapeutics to tumor cells is extremely important for cancer gene therapy. Various therapeutic strategies include delivery of DNA-therapeutics such as immunostimulatory or suicide genes and delivery of siRNA-therapeutics able to silence expressio...